Compound information
- Natural Products
- ZC828103
- Molecular Formula
- C14H19NO4
- Molecular Weight
- 265.131408088 g/mol
- Structure
-
- IUPAC Name
- (2R,3S)-2-(benzyloxycarbonylamino)-3-methyl-pentanoic acid
- InChI
- InChI=1S/C14H19NO4/c1-3-10(2)12(13(16)17)15-14(18)19-9-11-7-5-4-6-8-11/h4-8,10,12H,3,9H2,1-2H3,(H,15,18)(H,16,17)/t10-,12+/m0/s1
- InChI Key
- JSHXJPFZKBRLFU-CMPLNLGQSA-N
- SMILES
- CC[C@H](C)[C@@H](NC(=O)OCc1ccccc1)C(=O)O
- Source
- ZINC000002389678
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.63 Å2 | LogP | 2.589 |
LogS | -3.051 | LogD | 1.846 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.007 | Pgp substrate | 0.002 |
HIA | 0.96 | F20 % | 0.993 |
F30 % | 0.864 | Caco-2 | -5.183 |
MDCK | -4.86 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.864 | PPB | 66.798 |
VD | 0.242 | Fu | 0.752 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.016 | CYP1A2 substrate | 0.631 |
CYP2A6 substrate | 0.384 | CYP2B6 substrate | 0.518 |
CYP2C19 inhibitor | 0.078 | CYP2C19 substrate | 0.863 |
CYP2C8 substrate | 0.661 | CYP2C9 inhibitor | 0.044 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.046 |
CYP2D6 substrate | 0.847 | CYP2E1 substrate | 0.421 |
CYP3A4 inhibitor | 0.015 | CYP3A4 substrate | 0.984 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.925 | CL | 2.2 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.002 | Hepatotoxicity | 0.573 |
Mutagenicity | 0.014 | Rat Oral Acute Toxicity | 0.023 |
FDAMDD | 0.031 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.007 | Eye Corrosion | 0.004 |
Eye Irritation | 0.613 | Respiratory Toxicity | 0.002 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.251 | IGC50 | 2.048 |
LC50FM | 3.494 | LC50DM | 4.012 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.319 | NR-AR-LBD | 0.31 |
NR-AhR | 0.003 | NR-Aromatase | 0.044 |
NR-ER | 0.343 | NR-ER-LBD | 0.336 |
NR-PPAR-gamma | 0.488 | SR-ARE | 0.035 |
SR-ATAD5 | 0.272 | SR-HSE | 0.075 |
SR-MMP | 0.009 | SR-p53 | 0.022 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.